Related Experiment Videos
[The serum insulin level in severe hepatitis patients]
Hunan Yi Ke Da Xue Xue Bao = Hunan Yike Daxue Xuebao = Bulletin of Hunan Medical University
|January 1, 1997
Summary
Elevated serum insulin (SI) levels indicate increased severity in severe hepatitis patients. Higher SI levels correlate with poorer outcomes and disease progression, aiding in prognosis.
Area of Science:
- Hepatology
- Endocrinology
- Biochemistry
Context:
- Severe hepatitis, encompassing chronic severe hepatitis (CSH) and subacute severe hepatitis (SSH), presents significant clinical challenges.
- Assessing disease severity and patient prognosis in hepatitis is crucial for effective management.
Purpose:
- To investigate the relationship between serum insulin (SI) levels and the severity and outcomes of severe hepatitis.
- To determine if SI levels can serve as a prognostic biomarker in patients with severe hepatitis.
Summary:
- Serum insulin levels were measured in 36 patients with severe hepatitis using radioimmunoassay (RIA).
- Significantly elevated SI levels were observed in both CSH and SSH patients compared to healthy controls (P < 0.01).
- Higher SI levels were associated with mortality (P < 0.05) and were more pronounced during the fastigium stage compared to convalescence (P < 0.05).
Impact:
- Serum insulin levels may serve as a valuable tool for evaluating disease severity in severe hepatitis.
- SI levels show potential as a prognostic indicator for estimating patient outcomes in severe hepatitis.